Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.dld.2020.09.010

http://scihub22266oqcxt.onion/10.1016/j.dld.2020.09.010
suck pdf from google scholar
32988758!7494329!32988758
unlimited free pdf from europmc32988758    free
PDF from PMC    free
html from PMC    free

Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32988758&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215

suck abstract from ncbi

pmid32988758      Dig+Liver+Dis 2021 ; 53 (2): 146-152
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • COVID 19 and liver: An A-Z literature review #MMPMID32988758
  • Metawea MI; Yousif WI; Moheb I
  • Dig Liver Dis 2021[Feb]; 53 (2): 146-152 PMID32988758show ga
  • The coronavirus pandemic has changed the priorities of the whole medical society. During the clinical course of COVID-19, it has been observed that hepatic injury occurs in a significant proportion of patients, particularly in those with severe or critical illness. In this literature review, we summarize the most recent studies, which covered the pathophysiology of COVID-19 induced liver injury including; hepatic pathological findings, therapy related liver damage, and the effects of the viral infection on pre-existing liver diseasesin context of the most recent recommendations. Conclusions: This review sheds light on the impact of COVID-19 infection on the liver, as well as the prognostic effect of liver laboratory markers on disease outcome. Temporal variations in liver parameters during disease course as well as different patterns of derangement are depicted. More intensive surveillance and individualized therapeutic approaches should be tailored for immunocompromised patients with advanced liver disease, hepatocellular carcinoma, and liver transplant patients. Despite the limited studies on COVID-19 infected patients with preexisting liver disease, this comprehensive overview provides a perspective on the management of liver disease during COVID-19.
  • |*COVID-19 Drug Treatment[MESH]
  • |*COVID-19/physiopathology[MESH]
  • |*Liver Diseases/diagnosis/etiology/therapy/virology[MESH]
  • |*Liver/metabolism/pathology[MESH]
  • |Antiviral Agents/*pharmacology[MESH]
  • |Chemical and Drug Induced Liver Injury/diagnosis/etiology/prevention & control[MESH]
  • |Humans[MESH]
  • |Liver Function Tests/methods[MESH]
  • |Patient Care Management/*methods[MESH]
  • |Prognosis[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box